Heterocyclic compounds

US11420961B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Joerg Benz · Rheinfelden (Baden), DE
• Uwe Grether · Weil am Rhein, DE
• Benoit Hornsperger · Altkirch, FR
• Buelent Kocer · Basel, CH
• Bernd Kuhn · Sursee, CH
• Hans Richter · Weil am Rhein, DE
• Satoshi TSUCHIYA · Shizuoka, JP
• Charles BELL · Basel, CH
• Xiang WU · Hubei, CN
• Xiaofei Yan · Hubei, CN
• Luca Gobbi · Muttenz, CH

Key dates

• Filing date: May 27, 2020
• Grant date: Aug 23, 2022
• Expiry date: May 27, 2040

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides new heterocyclic compounds having the general formula (IA) wherein A, L, X, Y, m, n, R1 and R2 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.